Versarien plc (LON:VRS – Get Free Report)’s share price hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as GBX 0.03 ($0.00) and last traded at GBX 0.03 ($0.00), with a volume of 48241461 shares traded. The stock had previously closed at GBX 0.03 ($0.00).
Versarien Trading Down 10.3 %
The business’s 50 day simple moving average is GBX 0.03 and its 200 day simple moving average is GBX 0.04. The company has a debt-to-equity ratio of 655.61, a current ratio of 1.58 and a quick ratio of 1.67. The company has a market capitalization of £605,800.00, a price-to-earnings ratio of -0.65 and a beta of 1.13.
Versarien (LON:VRS – Get Free Report) last posted its quarterly earnings data on Thursday, March 27th. The company reported GBX (0.33) ($0.00) EPS for the quarter. Versarien had a negative net margin of 225.06% and a negative return on equity of 216.70%. Research analysts anticipate that Versarien plc will post -332.0000161 EPS for the current year.
Versarien Company Profile
Versarien plc provides engineering solutions for various industry sectors in the United Kingdom, rest of Europe, North America, and internationally. The company operates in two segments, Technology Business and Mature Business. It offers Nanene, a few-layer graphene; Polygrene, a graphene enhanced polymer; Hexotene, a few-layer hexagonal boron nitride nano-platelet powder; and graphene-based nanomaterials for energy storage devices, as well as a range of electrically conductive graphene inks for various printing processes, substrates, and applications under the Graphinks name.
Recommended Stories
- Five stocks we like better than Versarien
- Stock Average Calculator
- MarketBeat Week in Review – 03/24 – 03/28
- When to Sell a Stock for Profit or Loss
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- What Are the FAANG Stocks and Are They Good Investments?
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Versarien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versarien and related companies with MarketBeat.com's FREE daily email newsletter.